Pricing Log in Create free account
Saturday 17 October 2026 Export MRK’s income statement to Excel — free account

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS fell 130.7%, free cash flow grew 77.0% and total debt rose 50.4%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for five.

145.95 0.76 +0.52%
Market cap
$358.2B
P/E
117×
Fwd P/E
53.9×
Dividend yield
2.33%
F-score
4/9
Altman Z
3.77
Beneish M
−2.27
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Merck & Co., Inc. (MRK) Current ratio

Alert me on Current ratio

Merck & Co., Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.3×, down 0.2× from fiscal 2025 (1.5×). Over the past ten years it has ranged from 1.0× (fiscal 2020) to 1.8× (fiscal 2016); the current reading is higher than 82% of that period. That is in line with the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.5× 12.58%
FY2024 1.4× 8.99%
FY2023 1.3× (15.04%)
FY2022 1.5× 16.24%
FY2021 1.3× 24.78%
FY2020 1.0× (17.86%)
FY2019 1.2× 6.15%
FY2018 1.2× (12.42%)
FY2017 1.3× (25.23%)
FY2016 1.8× 14.84%

Quarterly newest first

Period Current ratio Change
Jun 2026 1.3× 1.79%
Mar 2026 1.3× (15.41%)
Dec 2025 1.5× (7.52%)
Sep 2025 1.7× 16.69%
42 more quarters

Against its own ten years

Low 1.0× High 1.8×
Ten-year median 1.3×
Current reading's percentile 82

Current ratio against peers

Company Current ratio
AMGN Amgen Inc. compare 1.4×
MRK Merck & Co., Inc. 1.3×
PFE Pfizer Inc. compare 1.3×
GILD Gilead Sciences, Inc. compare 1.3×
JNJ Johnson & Johnson compare 1.1×
AZN AstraZeneca PLC compare 0.9×
NVO Novo Nordisk A/S compare 0.9×
NVS Novartis AG compare 0.9×
ABBV AbbVie Inc. compare 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on MRK